{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:21:48Z","timestamp":1791408108633,"version":"4.3.3"},"reference-count":106,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T00:00:00Z","timestamp":1729036800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172362"],"award-info":[{"award-number":["82172362"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81972012"],"award-info":[{"award-number":["81972012"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022963","name":"Key Research and Development Program of Zhejiang Province","doi-asserted-by":"publisher","award":["2022C03037"],"award-info":[{"award-number":["2022C03037"]}],"id":[{"id":"10.13039\/100022963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LY24H200001"],"award-info":[{"award-number":["LY24H200001"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LY22H200002"],"award-info":[{"award-number":["LY22H200002"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.isci.2024.111211","type":"journal-article","created":{"date-parts":[[2024,10,19]],"date-time":"2024-10-19T11:07:11Z","timestamp":1729336031000},"page":"111211","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Serum human epididymis Protein-4 outperforms conventional biomarkers in the early detection of non-small cell lung cancer"],"prefix":"10.1016","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0322-1381","authenticated-orcid":false,"given":"Mohammad Erfan","family":"Zare","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atefeh","family":"Nasir Kansestani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuanlan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanzhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzhen","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2024.111211_bib1","article-title":"Non-small cell lung cancer (NSCLC): A review of risk factors, diagnosis, and treatment","volume":"102","author":"Alduais","year":"2023","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.isci.2024.111211_bib2","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.3390\/curroncol29030150","article-title":"Non-Small-Cell Lung Cancer in 2022: A Review for General Practitioners in Oncology","volume":"29","author":"Mithoowani","year":"2022","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.isci.2024.111211_bib3","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ccm.2019.10.004","article-title":"Biomarkers in Lung Cancer","volume":"41","author":"Sears","year":"2020","journal-title":"Clin. Chest Med."},{"key":"10.1016\/j.isci.2024.111211_bib4","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1177\/1724600819868234","article-title":"CYFRA21-1 tests in the diagnosis of non-small cell lung cancer: A meta-analysis","volume":"34","author":"Fu","year":"2019","journal-title":"Int. J. Biol. Markers"},{"key":"10.1016\/j.isci.2024.111211_bib5","article-title":"HE4 as a biomarker for diagnosis of lung cancer: A meta-analysis","volume":"98","author":"He","year":"2019","journal-title":"M\u00e9d."},{"key":"10.1016\/j.isci.2024.111211_bib6","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.21037\/jtd.2019.06.72","article-title":"Diagnostic accuracy of human epididymis secretory protein 4 for lung cancer: a systematic review and meta-analysis","volume":"11","author":"Yan","year":"2019","journal-title":"J.\u00a0Thorac. Dis."},{"key":"10.1016\/j.isci.2024.111211_bib7","doi-asserted-by":"crossref","first-page":"67","DOI":"10.14715\/cmb\/2017.64.15.11","article-title":"Combined detection of CEA and CA125 for the diagnosis for lung cancer: A meta-analysis","volume":"64","author":"Wu","year":"2018","journal-title":"Cell. Mol. Biol."},{"key":"10.1016\/j.isci.2024.111211_bib8","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-06689-4","article-title":"Comparison of faecal protein biomarkers\u2019 diagnostic accuracy for colorectal advanced neoplasms: a systematic review and meta-analysis","volume":"12","author":"Nasir Kansestani","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2024.111211_bib9","first-page":"557","article-title":"Procalcitonin Has Good Accuracy for Prognosis of Critical Condition and Mortality in COVID-19: A Diagnostic Test Accuracy Systematic Review and Meta-analysis. Iran","volume":"19","author":"Zare","year":"2020","journal-title":"J.\u00a0Allergy. Asthma. Immunol."},{"key":"10.1016\/j.isci.2024.111211_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jclinepi.2019.12.007","article-title":"Methods and reporting of systematic reviews of comparative accuracy were deficient: a methodological survey and proposed guidance","volume":"121","author":"Takwoingi","year":"2020","journal-title":"J.\u00a0Clin. Epidemiol."},{"key":"10.1016\/j.isci.2024.111211_bib11","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/ajcp\/aqx147","article-title":"Effectiveness of Practices to Support Appropriate Laboratory Test Utilization: A Laboratory Medicine Best Practices Systematic Review and Meta-Analysis","volume":"149","author":"Rubinstein","year":"2018","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.isci.2024.111211_bib12","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1373\/clinchem.2010.157131","article-title":"Laboratory medicine best practices: systematic evidence review and evaluation methods for quality improvement","volume":"57","author":"Christenson","year":"2011","journal-title":"Clin. Chem."},{"key":"10.1016\/j.isci.2024.111211_bib13","first-page":"22","article-title":"Assessing sensitivity and specificity of telomerase, parathyroid hormone, carcinoembryogenic antigen (CEA) and cyfra-21-1 in lung cancer diagnosis","volume":"11","author":"Alani","year":"2007","journal-title":"Feyz"},{"key":"10.1016\/j.isci.2024.111211_bib14","first-page":"3726","article-title":"The diagnostic value of miR-135b combined with HE4 CEA and CA153 in early non-small cell lung cancer","volume":"28","author":"Chang","year":"2020","journal-title":"Mod. Oncol."},{"key":"10.1016\/j.isci.2024.111211_bib15","first-page":"383","article-title":"Utility of serum cytokeratin 19 fragment (CYFRA 21-1) and carcinoembryonic antigen (CEA) as tumour markers for non-small cell lung cancer","volume":"83","author":"Chantapet","year":"2000","journal-title":"J.\u00a0Med. Assoc. Thai."},{"key":"10.1016\/j.isci.2024.111211_bib16","first-page":"11295","article-title":"Diagnostic value of Cyfra21-1, SCC and CEA for differentiation of early-stage NSCLC from benign lung disease","volume":"8","author":"Chen","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.isci.2024.111211_bib17","doi-asserted-by":"crossref","first-page":"S400","DOI":"10.4103\/0973-1482.174180","article-title":"Diagnostic value of CYFRA 21-1 and carcinoembryonic antigen in diagnosis of operable lung cancer from benign lung disease","volume":"14","author":"Chen","year":"2018","journal-title":"J.\u00a0Cancer Res. Therapeut."},{"key":"10.1016\/j.isci.2024.111211_bib18","first-page":"248","article-title":"Serum ADAM8, CEA and plasma M2- Value of PK alone and in combination in the early diagnosis of non-small cell lung cancer","volume":"23","author":"Chen","year":"2016","journal-title":"Labeled Immunoass. Clin."},{"key":"10.1016\/j.isci.2024.111211_bib19","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1177\/17246008211049446","article-title":"The diagnostic value of the combination of carcinoembryonic antigen, squamous cell carcinoma-related antigen, CYFRA 21-1, neuron-specific enolase, tissue polypeptide antigen, and progastrin-releasing peptide in small cell lung cancer discrimination","volume":"36","author":"Chen","year":"2021","journal-title":"Int. J. Biol. Markers"},{"key":"10.1016\/j.isci.2024.111211_bib20","first-page":"189","article-title":"Cytokeratin 19 fragment CYFRA 21-1 compared with carcinoembryonic antigen, squamous cell carcinoma antigen and neuron-specific enolase in lung cancer. Results of an international multicentre study","volume":"32","author":"Ebert","year":"1994","journal-title":"Eur. J. Clin. Chem. Clin. Biochem."},{"key":"10.1016\/j.isci.2024.111211_bib21","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/bjc.1994.95","article-title":"Evaluation of a new tumour marker in patients with non-small-cell lung cancer: Cyfra 21.1","volume":"69","author":"van der Gaast","year":"1994","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.isci.2024.111211_bib22","first-page":"886","article-title":"Diagnostic value of serum tumor markers CEA, CYFRA21-1, SCCAg, NSE and ProGRP for lung cancers of different pathological types","volume":"42","author":"Gao","year":"2022","journal-title":"J.\u00a0South. Med. Univ."},{"key":"10.1016\/j.isci.2024.111211_bib23","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0954-6111(97)90049-4","article-title":"Comparison of cytokeratin fragment 19 (CYFRA 21-1), tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA) as tumour markers in bronchogenic carcinoma","volume":"91","author":"Huang","year":"1997","journal-title":"Respir. Med."},{"key":"10.1016\/j.isci.2024.111211_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lfs.2017.12.020","article-title":"Thymidine kinase 1 combined with CEA, CYFRA21-1 and NSE improved its diagnostic value for lung cancer","volume":"194","author":"Jiang","year":"2018","journal-title":"Life Sci."},{"key":"10.1016\/j.isci.2024.111211_bib25","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1093\/clinchem\/48.11.1931","article-title":"Carcinoembryonic antigen, squamous cell carcinoma antigen, CYFRA 21-1, and neuron-specific enolase in squamous cell lung cancer patients","volume":"48","author":"Kulpa","year":"2002","journal-title":"Clin. Chem."},{"key":"10.1016\/j.isci.2024.111211_bib26","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1378\/chest.109.4.995","article-title":"CYFRA 21-1 enzyme-linked immunosorbent assay. Evaluation as a tumor marker in non-small cell lung cancer","volume":"109","author":"Lai","year":"1996","journal-title":"Chest"},{"key":"10.1016\/j.isci.2024.111211_bib27","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.7150\/jca.23973","article-title":"Serum VEGF levels in the early diagnosis and severity assessment of non-small cell lung cancer","volume":"9","author":"Lai","year":"2018","journal-title":"J.\u00a0Cancer"},{"key":"10.1016\/j.isci.2024.111211_bib28","first-page":"1444","article-title":"Clinical value of serum human epididymis protein 4 with carcinoembryonic antigen and cytokeratin 19 fragment in the diagnosis of non-small cell lung cancer","volume":"39","author":"Li","year":"2020","journal-title":"J.\u00a0Cardiovasc."},{"key":"10.1016\/j.isci.2024.111211_bib29","doi-asserted-by":"crossref","first-page":"729","DOI":"10.4149\/neo_2022_220207N144","article-title":"New insights into the diagnostic characteristics and clinical application of serum biomarkers for lung cancer, and human epididymis protein 4 as a new biomarker?","volume":"69","author":"Li","year":"2022","journal-title":"Neoplasma"},{"key":"10.1016\/j.isci.2024.111211_bib30","first-page":"960","article-title":"Significance of serum TK-1, SE-CAD expression and combined HE4, CEA and CYFRA21-1 detection in the diagnosis of non-small cell lung cancer. Labeled Immunoass","volume":"26","author":"Liu","year":"2019","journal-title":"Clin. Med."},{"key":"10.1016\/j.isci.2024.111211_bib31","doi-asserted-by":"crossref","first-page":"4891","DOI":"10.7314\/APJCP.2015.16.12.4891","article-title":"Clinical Evaluation of Tumor Markers for Diagnosis in Patients with Non-small Cell Lung Cancer in China","volume":"16","author":"Ma","year":"2015","journal-title":"Asian Pac. J. Cancer Prev. APJCP"},{"key":"10.1016\/j.isci.2024.111211_bib32","doi-asserted-by":"crossref","first-page":"18901","DOI":"10.18632\/oncotarget.14782","article-title":"Identification of serum proteins and multivariate models for diagnosis and therapeutic monitoring of lung cancer","volume":"8","author":"Ma","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.isci.2024.111211_bib33","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000224628","article-title":"Usefulness of serum tumor markers, including progastrin-releasing peptide, in patients with lung cancer: correlation with histology","volume":"30","author":"Molina","year":"2009","journal-title":"Tumour Biol."},{"key":"10.1016\/j.isci.2024.111211_bib34","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1002\/(SICI)1097-0142(19980515)82:10<1850::AID-CNCR6>3.0.CO;2-R","article-title":"Evaluation of tissue polypeptide specific antigen, CYFRA 21-1, and carcinoembryonic antigen in nonsmall cell lung carcinoma: does the combined use of cytokeratin markers give any additional information?","volume":"82","author":"Nisman","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.isci.2024.111211_bib35","first-page":"689","article-title":"Comparison of cytokeratin fragment 19 (CYFRA 21-1), tissue polypeptide antigen (TPA) and tissue polypeptide specific antigen (TPS) as tumour markers in lung cancer","volume":"31","author":"Stieber","year":"1993","journal-title":"Eur. J. Clin. Chem. Clin. Biochem."},{"key":"10.1016\/j.isci.2024.111211_bib36","first-page":"97","article-title":"The value of serum tumor marker CA125 and CEA in the diagonosis of non-small cell lung cancer","volume":"11","author":"Wang","year":"2008","journal-title":"Chin. J. Lung Cancer"},{"key":"10.1016\/j.isci.2024.111211_bib37","doi-asserted-by":"crossref","first-page":"9611","DOI":"10.7314\/APJCP.2014.15.22.9611","article-title":"Clinical utility of haptoglobin in combination with CEA, NSE and CYFRA21-1 for diagnosis of lung cancer","volume":"15","author":"Wang","year":"2014","journal-title":"Asian Pac. J. Cancer Prev. APJCP"},{"key":"10.1016\/j.isci.2024.111211_bib38","first-page":"162","article-title":"Diagnosis value of serum human eididymis 4 in the non-small cell lung cancer","volume":"21","author":"Wang","year":"2023","journal-title":"Oncol. Prog."},{"key":"10.1016\/j.isci.2024.111211_bib39","first-page":"187","article-title":"Clinical value of plasma M2-PK combined detection with serum CEA and ADAM8 in the diagnosis of non-small cell lung cancer","volume":"46","author":"Wang","year":"2017","journal-title":"J.\u00a0Media Res."},{"key":"10.1016\/j.isci.2024.111211_bib40","first-page":"586","article-title":"Diagnostic value of three tumor markers (tumor M2-PK, CEA, CYFRA21-1) as analyzed with application of logistic regression and ROC curve in patients with non-small-cell lung cancer","volume":"21","author":"Xiaoqin","year":"2008","journal-title":"J Radioimmunol"},{"key":"10.1016\/j.isci.2024.111211_bib41","doi-asserted-by":"crossref","first-page":"587","DOI":"10.2147\/OTT.S152957","article-title":"Application of serum microRNA-9-5p, 21-5p, and 223-3p combined with tumor markers in the diagnosis of non-small-cell lung cancer in Yunnan in southwestern China","volume":"11","author":"Yang","year":"2018","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.isci.2024.111211_bib42","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.cca.2016.02.002","article-title":"Serum human epididymis protein 4 (HE4) may be a better tumor marker in early lung cancer","volume":"455","author":"Zeng","year":"2016","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.isci.2024.111211_bib43","first-page":"1159","article-title":"Value analysis of serum CYFRA21-1, CEA in combination with MMP-1 and SAA in the detection of non-small cell lung cancer","volume":"25","author":"Zhai","year":"2018","journal-title":"Labeled Immunoass. Clin."},{"key":"10.1016\/j.isci.2024.111211_bib44","first-page":"116","article-title":"Serolysis integratin-like metalloproteinase 8, plasma M2Value of pyruvate kinase detection in early diagnosis of non-small cell lung cancer","volume":"24","author":"Zhou","year":"2010","journal-title":"Chinese J Pract. Treat"},{"key":"10.1016\/j.isci.2024.111211_bib45","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0959-8049(97)89010-7","article-title":"Diagnostic and prognostic value of Cyfra 21-1 compared with other tumour markers in patients with non-small cell lung cancer: a prospective study of 116 patients","volume":"33","author":"Br\u00e9chot","year":"1997","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.isci.2024.111211_bib46","first-page":"3721","article-title":"Diagnostic value of HE4, CYFRA21-1 in combination with and TPS for early diagnosis of non-small cell lung cancer","volume":"32","author":"Chen","year":"2016","journal-title":"J.\u00a0Pract. Med."},{"key":"10.1016\/j.isci.2024.111211_bib47","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ejca.2010.08.006","article-title":"Diagnostic and prognostic role of plasma levels of two forms of cytokeratin 18 in patients with non-small-cell lung cancer","volume":"47","author":"De Petris","year":"2011","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.isci.2024.111211_bib48","first-page":"44","article-title":"Diagnostic Efficiency of HE4 and CYFRA 21-1 in Patients with Lung Cancer","volume":"25","author":"Dikmen","year":"2015","journal-title":"Int J Hem Onc"},{"key":"10.1016\/j.isci.2024.111211_bib49","first-page":"62","article-title":"Relations of Serum Levels of Cyfra21-1\uff0c HE4 and TPS\uff0c and Neutrophil to Lymphocyte Ratio to Non-small Cell Lung Cancer","volume":"27","author":"Du","year":"2019","journal-title":"PJCCPVD"},{"key":"10.1016\/j.isci.2024.111211_bib50","first-page":"1118","article-title":"Diagnosis value of the detection of CYFRA21-1 in non-small cell lung cancer","volume":"13","author":"Gu","year":"2010","journal-title":"Chin. J. Lung Cancer"},{"key":"10.1016\/j.isci.2024.111211_bib51","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3904\/kjim.1996.11.1.50","article-title":"A comparison of serum CYFRA 21-1 and SCC Ag in the diagnosis of squamous cell lung carcinoma","volume":"11","author":"Kim","year":"1996","journal-title":"Korean J. Intern. Med. (Engl. Ed.)"},{"key":"10.1016\/j.isci.2024.111211_bib52","doi-asserted-by":"crossref","first-page":"591","DOI":"10.2217\/bmm.13.55","article-title":"CYFRA21-1 as a serum tumor marker for follow-up patients with squamous cell lung carcinoma and oropharynx squamous cell carcinoma","volume":"7","author":"Liu","year":"2013","journal-title":"Biomarkers Med."},{"key":"10.1016\/j.isci.2024.111211_bib53","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3892\/ol.2023.13841","article-title":"Detection of serum HE4 levels contributes to the diagnosis of lung cancer","volume":"25","author":"Li","year":"2023","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.isci.2024.111211_bib54","first-page":"625","article-title":"The significance of serum HE4, VEGF and CYFRA21-1 in the diagnosis of non-small cell lung cancer and their relationship with clinicopathological features","volume":"40","author":"Liu","year":"2020","journal-title":"J.\u00a0Xuzhou Med. Univ."},{"key":"10.1016\/j.isci.2024.111211_bib55","doi-asserted-by":"crossref","first-page":"764","DOI":"10.2169\/internalmedicine.35.764","article-title":"Clinical usefulness of serum cytokeratin 19 fragment as a tumor marker for lung cancer","volume":"35","author":"Maeda","year":"1996","journal-title":"Intern. Med."},{"key":"10.1016\/j.isci.2024.111211_bib56","first-page":"485","article-title":"CYFRA 21-1 in non-small cell lung cancer--standardisation and application during diagnosis","volume":"32","author":"Pavi\u0107evi\u0107","year":"2008","journal-title":"Coll. Antropol."},{"key":"10.1016\/j.isci.2024.111211_bib57","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1164\/ajrccm.154.3.8810612","article-title":"Cytokeratins as serum markers in lung cancer: a comparison of CYFRA 21-1 and TPS","volume":"154","author":"Pujol","year":"1996","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.isci.2024.111211_bib58","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0169-5002(00)00186-0","article-title":"Cyfra 21-1, neuron specific enolase and prognosis of non-small cell lung cancer: prospective study in 621 patients","volume":"31","author":"Pujol","year":"2001","journal-title":"Lung Cancer"},{"key":"10.1016\/j.isci.2024.111211_bib59","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/0959-8049(94)90528-2","article-title":"CYFRA 21-1, a sensitive and specific new tumour marker for squamous cell lung cancer. Report of the first European multicentre evaluation. CYFRA 21-1 Multicentre Study Group","volume":"30","author":"Rastel","year":"1994","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.isci.2024.111211_bib60","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.21037\/jtd.2016.06.21","article-title":"Role of plasma MicroRNAs in the early diagnosis of non-small-cell lung cancers: a case-control study","volume":"8","author":"Wang","year":"2016","journal-title":"J.\u00a0Thorac. Dis."},{"key":"10.1016\/j.isci.2024.111211_bib61","first-page":"1073","article-title":"Correlation between serum CYFRA21-1 and HE4 levels and pathological features and prognosis in patients with non-small cell lung cancer","volume":"34","author":"Wang","year":"2022","journal-title":"Med J West China"},{"key":"10.1016\/j.isci.2024.111211_bib62","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1378\/chest.108.1.163","article-title":"Cyfra 21-1 as a biologic marker of non-small cell lung cancer. Evaluation of sensitivity, specificity, and prognostic role","volume":"108","author":"Wieskopf","year":"1995","journal-title":"Chest"},{"key":"10.1016\/j.isci.2024.111211_bib63","doi-asserted-by":"crossref","first-page":"C215","DOI":"10.4103\/0973-1482.145878","article-title":"Serum cyfra21-1 as a biomarker in patients with nonsmall cell lung cancer","volume":"10","author":"Zhao","year":"2014","journal-title":"J.\u00a0Cancer Res. Therapeut."},{"key":"10.1016\/j.isci.2024.111211_bib64","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7754\/Clin.Lab.2016.160818","article-title":"Evaluation of HE4 in the Diagnosis and Follow Up of Non-Small Cell Lung Cancers","volume":"63","author":"Huang","year":"2017","journal-title":"Clin. Lab."},{"key":"10.1016\/j.isci.2024.111211_bib65","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1007\/s13277-012-0356-9","article-title":"Serum HE4 as a diagnostic and prognostic marker for lung cancer","volume":"33","author":"Iwahori","year":"2012","journal-title":"Tumour Biol."},{"key":"10.1016\/j.isci.2024.111211_bib66","first-page":"137","article-title":"Serum Human Epididymis Protein 4 (HE4) As A Diagnostic And Follow-Up Biomarker in Patients With Non-Small Cell Lung Cancer","volume":"27","author":"Kumbasar","year":"2017","journal-title":"Int J Hem Onc"},{"key":"10.1016\/j.isci.2024.111211_bib67","article-title":"Serum HE4: An Independent Prognostic Factor in Non-Small Cell Lung Cancer","volume":"10","author":"PJ","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2024.111211_bib68","first-page":"2499","article-title":"Clinical value of human epididymal protein 4 and amyloid A in the diagnosis of non-small cell lung cancer","volume":"31","author":"Lei","year":"2021","journal-title":"Chin. J. Health Lab. Technol."},{"key":"10.1016\/j.isci.2024.111211_bib69","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.5588\/ijtld.13.0058","article-title":"Evaluating the clinical significance of serum HE4 levels in lung cancer and pulmonary tuberculosis","volume":"17","author":"Liu","year":"2013","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"10.1016\/j.isci.2024.111211_bib70","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.7754\/Clin.Lab.2018.180222","article-title":"Serum Human Epididymis Secretory Protein 4 (HE4) is a Potential Prognostic Biomarker in Non-Small Cell Lung Cancer","volume":"64","author":"Mo","year":"2018","journal-title":"Clin. Lab."},{"key":"10.1016\/j.isci.2024.111211_bib71","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1515\/cclm-2014-0041","article-title":"Serum human epididymis protein 4 (HE4) as a tumor marker in men with lung cancer","volume":"52","author":"Nagy","year":"2014","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.isci.2024.111211_bib72","first-page":"2497","article-title":"Relationship between serum ProGRP, SCCAg and HE4 and pathological characteristics of patients with non-small cell lung cancer and their diagnostic value","volume":"20","author":"Wang","year":"2020","journal-title":"Adv. Mod. Biomed."},{"key":"10.1016\/j.isci.2024.111211_bib73","doi-asserted-by":"crossref","first-page":"i254","DOI":"10.1093\/qjmed\/hcab103.014","article-title":"Prospective Analysis of Serum HE4 as an Independent Prognostic Factor in Non Small Cell Lung Cancer","volume":"114","author":"Wasly","year":"2021","journal-title":"QJM An Int. J. Med."},{"key":"10.1016\/j.isci.2024.111211_bib74","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1007\/s13277-012-0499-8","article-title":"Serum level of HE4 is closely associated with pulmonary adenocarcinoma progression","volume":"33","author":"Yamashita","year":"2012","journal-title":"Tumour Biol."},{"key":"10.1016\/j.isci.2024.111211_bib75","first-page":"2652","article-title":"Clinical value of serum tumor M2 pyruvate kinase in the diagnosis of non-small cell lung cancer","volume":"28","author":"Meng","year":"2017","journal-title":"Hainan Med"},{"key":"10.1016\/j.isci.2024.111211_bib76","first-page":"1623","article-title":"Clinical significance of detection of plasma PKM2 in patients with NSCLC","volume":"39","author":"Su","year":"2017","journal-title":"Heb. Med. J."},{"key":"10.1016\/j.isci.2024.111211_bib77","doi-asserted-by":"crossref","first-page":"7335","DOI":"10.1111\/jcmm.16762","article-title":"Serum tumour M2-pyruvate kinase as a biomarker for diagnosis and prognosis of early-stage non-small cell lung cancer","volume":"25","author":"Xu","year":"2021","journal-title":"J.\u00a0Cell Mol. Med."},{"key":"10.1016\/j.isci.2024.111211_bib78","first-page":"33","article-title":"Clinical significance of SAA and TSGF detection before and after surgery in patients with non-small cell lung cancer","volume":"18","author":"Wang","year":"2011","journal-title":"Chinese J. Clin. Oncol. Rehabil."},{"key":"10.1016\/j.isci.2024.111211_bib79","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3892\/ol.2021.13130","article-title":"Diagnostic and prognostic value of serum miR-145 and vascular endothelial growth factor in non-small cell lung cancer","volume":"23","author":"Geater","year":"2022","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.isci.2024.111211_bib80","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1002\/cncr.11529","article-title":"Serum vascular endothelial growth factor-C level in patients with primary nonsmall cell lung carcinoma: a possible diagnostic tool for lymph node metastasis","volume":"98","author":"Tamura","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.isci.2024.111211_bib81","first-page":"14","article-title":"Diagnostic value of serum VEGF, IL-6 and CRP in patients with intermediate and advanced NSCLC. Chinese Pract","volume":"179","author":"Wang","year":"2022","journal-title":"M\u00e9d."},{"key":"10.1016\/j.isci.2024.111211_bib82","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1096\/fba.2022-00002","article-title":"Elevated serum Cripto-1 and VEGF levels in patients with non-small cell lung cancer","volume":"4","author":"Xu","year":"2022","journal-title":"FASEB Bioadv."},{"key":"10.1016\/j.isci.2024.111211_bib83","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.31557\/APJCP.2019.20.8.2405","article-title":"The Application Value of Serum HE4 in the Diagnosis of Lung Cancer","volume":"20","author":"Wang","year":"2019","journal-title":"Asian Pac. J. Cancer Prev. APJCP"},{"key":"10.1016\/j.isci.2024.111211_bib84","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2147\/OTT.S188832","article-title":"The diagnostic accuracy of liquid exosomes for lung cancer detection: a meta-analysis","volume":"12","author":"Song","year":"2019","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.isci.2024.111211_bib85","article-title":"Diagnostic value of microRNA-148\/152 family in non-small-cell lung cancer (NSCLC): A systematic review and meta-analysis","volume":"100","author":"Cheng","year":"2021","journal-title":"M\u00e9d."},{"key":"10.1016\/j.isci.2024.111211_bib86","doi-asserted-by":"crossref","first-page":"63283","DOI":"10.18632\/oncotarget.11446","article-title":"The accuracy of microRNA-210 in diagnosing lung cancer: a systematic review and meta-analysis","volume":"7","author":"Yang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.isci.2024.111211_bib87","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/1354750X.2017.1420822","article-title":"Diagnostic accuracy of MALDI-TOF mass spectrometry for non-small cell lung cancer: a meta-analysis","volume":"23","author":"Lu","year":"2018","journal-title":"Biomarkers"},{"key":"10.1016\/j.isci.2024.111211_bib88","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s40291-024-00715-z","article-title":"Diagnostic Accuracy of Exosomal Long Noncoding RNAs in Diagnosis of NSCLC: A Meta-Analysis","volume":"28","author":"Song","year":"2024","journal-title":"Mol. Diagn. Ther."},{"key":"10.1016\/j.isci.2024.111211_bib89","doi-asserted-by":"crossref","first-page":"C131","DOI":"10.4103\/0973-1482.145835","article-title":"The value of serum Cyfra21-1 as a biomarker in the diagnosis of patients with non-small cell lung cancer: a meta-analysis","volume":"10","author":"Cui","year":"2014","journal-title":"J.\u00a0Cancer Res. Therapeut."},{"key":"10.1016\/j.isci.2024.111211_bib90","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1186\/s12874-022-01788-2","article-title":"Meta-DiSc 2.0: a web application for meta-analysis of diagnostic test accuracy data","volume":"22","author":"Plana","year":"2022","journal-title":"BMC Med. Res. Methodol."},{"key":"10.1016\/j.isci.2024.111211_bib91","first-page":"1","article-title":"Prognostic Accuracy of Cardiovascular Disease Biomarkers in Patients with COVID-19: A Diagnostic Test Accuracy Meta-Analysis","volume":"16","author":"Nasir Kansestani","year":"2021","journal-title":"J.\u00a0Tehran Heart Cent."},{"key":"10.1016\/j.isci.2024.111211_bib92","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.3348\/kjr.2015.16.6.1175","article-title":"Systematic Review and Meta-Analysis of Studies Evaluating Diagnostic Test Accuracy: A Practical Review for Clinical Researchers-Part I. General Guidance and Tips","volume":"16","author":"Kim","year":"2015","journal-title":"Korean J. Radiol."},{"key":"10.1016\/j.isci.2024.111211_bib93","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.3348\/kjr.2015.16.6.1188","article-title":"Systematic Review and Meta-Analysis of Studies Evaluating Diagnostic Test Accuracy: A Practical Review for Clinical Researchers-Part II. Statistical Methods of Meta-Analysis","volume":"16","author":"Lee","year":"2015","journal-title":"Korean J. Radiol."},{"key":"10.1016\/j.isci.2024.111211_bib94","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0169-5002(95)00485-8","article-title":"CEA, CYFRA21-1 and SCC in non-small cell lung cancer","volume":"13","author":"Moro","year":"1995","journal-title":"Lung Cancer"},{"key":"10.1016\/j.isci.2024.111211_bib95","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/352670","article-title":"The Diagnostic Accuracy of HE4 in Lung Cancer: A Meta-Analysis","volume":"2015","author":"Cheng","year":"2015","journal-title":"Dis. Markers"},{"key":"10.1016\/j.isci.2024.111211_bib96","first-page":"339","article-title":"Why do cancer cells produce serum amyloid A acute-phase protein?","volume":"77","author":"Moshkovskii","year":"2012","journal-title":"Biochem."},{"key":"10.1016\/j.isci.2024.111211_bib97","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1186\/s12874-022-01788-2","article-title":"Meta-DiSc 2.0: a web application for meta-analysis of diagnostic test accuracy data","volume":"22","author":"Plana","year":"2022","journal-title":"BMC Med. Res. Methodol."},{"key":"10.1016\/j.isci.2024.111211_bib98","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0294236","article-title":"SRplot: A free online platform for data visualization and graphing","volume":"18","author":"Tang","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2024.111211_bib99","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.isci.2024.111211_bib100","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.isci.2024.111211_bib101","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1128\/CMR.00030-15","article-title":"Effectiveness of Preanalytic Practices on Contamination and Diagnostic Accuracy of Urine Cultures: a Laboratory Medicine Best Practices Systematic Review and Meta-analysis","volume":"29","author":"Larocco","year":"2016","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.isci.2024.111211_bib102","first-page":"10","article-title":"A Laboratory Medicine Best Practices Systematic Review and Meta-analysis of Nucleic Acid Amplification Tests (NAATs) and Algorithms Including NAATs for the Diagnosis of Clostridioides (Clostridium) difficile in Adults","volume":"32","author":"Kraft","year":"2019","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.isci.2024.111211_bib103","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1128\/CMR.00053-14","article-title":"Effectiveness of Practices To Increase Timeliness of Providing Targeted Therapy for Inpatients with Bloodstream Infections: a Laboratory Medicine Best Practices Systematic Review and Meta-analysis","volume":"29","author":"Buehler","year":"2016","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.isci.2024.111211_bib104","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1148\/radiology.143.1.7063747","article-title":"The meaning and use of the area under a receiver operating characteristic (ROC) curve","volume":"143","author":"Hanley","year":"1982","journal-title":"Radiology"},{"key":"10.1016\/j.isci.2024.111211_bib105","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1148\/radiology.148.3.6878708","article-title":"A method of comparing the areas under receiver operating characteristic curves derived from the same cases","volume":"148","author":"Hanley","year":"1983","journal-title":"Radiology"},{"key":"10.1016\/j.isci.2024.111211_bib106","article-title":"STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies","volume":"351","author":"Bossuyt","year":"2015","journal-title":"BMJ"}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004224024362?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004224024362?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T20:57:07Z","timestamp":1783371427000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004224024362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":106,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S2589004224024362"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2024.111211","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum human epididymis Protein-4 outperforms conventional biomarkers in the early detection of non-small cell lung cancer","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2024.111211","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"111211"}}